| CAS ID: | 1918143-53-9 |
| Molecular Formula: | C28H21F4NO7 |
| Molecular Weight: | 559.5 g/mol |
| Monoisotopic Mass: | 559.125 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C28H21F4NO7/c29-26(30)37-17-6-7-18-19(13-21(38-22(18)12-17)14-1-3-15(4-2-14)24(34)35)33-25(36)27(9-10-27)16-5-8-20-23(11-16)40-28(31,32)39-20/h1-8,11-12,19,21,26H,9-10,13H2,(H,33,36)(H,34,35)/t19-,21-/m1/s1 | See All |
| InChI Key: | QVDYQHXNAQHIKH-TZIWHRDSSA-N | |
| Smiles: | C1CC1(C2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4CC(OC5=C4C=CC(=C5)OC(F)F)C6=CC=C(C=C6)C(=O)O | See All |
| Molfile: |
Trial Record 1
| ClinicalTrial ID | NCT03119649 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | April 18, 2017 | Last Verified | November 16, 2018 |
| Sponsor | Galapagos NV | ||
Trial Record 2
| ClinicalTrial ID | NCT03045523 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | February 7, 2017 | Last Verified | November 21, 2017 |
| Sponsor | Galapagos NV | ||
| PubChem: | 121301049 |
| ChEMBL: |